CVE-2026-31071
Published: May 19, 2026· Updated: May 20, 2026
Official Description
API endpoints in LalanaChami Pharmacy Management System (commit 5c3d028) lack authentication middleware. Unauthenticated remote attackers can exploit this to dump all user records (including bcrypt password hashes) via /api/user/getUserData, modify drug inventory, and access private medical prescription data via /api/doctorOder.
Risk Analysis
This critical vulnerability in LalanaChami Pharmacy Management System (commit 5c3d028) allows unauthenticated remote attackers to access sensitive data. With a CVSS score of 9.1, this flaw can lead to the exposure of user records, drug inventory modifications, and private medical data.
No public exploit is currently known for this vulnerability. It is remotely exploitable with low attack complexity, making it a significant data breach risk.
Apply available patches or updates to the LalanaChami Pharmacy Management System. Implement robust authentication middleware for all API endpoints to prevent unauthorized access.
Technical Analysis
CVE-2026-31071 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.
The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.
A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), with a CVSS base score of 9.1.
CVSS v3.1 Vector Breakdown
Exploit & PoC Resources
All References (3)
Quick Facts
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2026-31071 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts